Skip to content

Clinical trials

Phase 3 Endometrial Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 3 Country / region: Canada Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20091
20121
20131
20161
20182
20192
20202
20212
20222
20232
20241
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting8
Recruiting7
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
AstraZeneca3
European Organisation for Research and Treatment of Cancer - EORTC2
Gynecologic Oncology Group2
Karyopharm Therapeutics Inc2
AEterna Zentaris1
ARCAGY/ GINECO GROUP1
BioNTech SE1
Centre hospitalier de l'Université de Montréal (CHUM)1
Ciusss de L'Est de l'Île de Montréal1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms27
Uterine Neoplasms3
Neoplasm Metastasis2
Ovarian Neoplasms2
Sarcoma2
Sarcoma, Endometrial Stromal2
Uterine Cervical Neoplasms2
Breast Neoplasms1
Carcinosarcoma1
Esophageal Neoplasms1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.